Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled Trial

20250 citationsJournal Articlehybrid Open Access

Authors

Eydie Miller-Ellis · Penn Presbyterian Medical Center

James H. Peace · United Medical Research Institute

Douglas G. Day · Applied Research Associates

Shérif M. El-Harazi · Glendale Community College

Sylvie Nisslé · Thea (France)

David Wirta · Smith-Kettlewell Eye Research Institute

Jason Bacharach

Abstract

PF bimatoprost 0.01% ophthalmic gel was noninferior to the preserved bimatoprost 0.01% ophthalmic solution, with similar safety and tolerability over 3 months.

Topics & Keywords

Glaucoma and retinal disorders Ophthalmology and Eye Disorders Corneal surgery and disorders

Publication Details

Published in: Journal of Glaucoma

Volume 34, Issue 11, pp. 880-887

DOI: 10.1097/ijg.0000000000002628

Field-Weighted Citation Impact: 0.00

Command Palette

Safety and Efficacy of a Preservative-Free Bimatoprost 0.01% Ophthalmic Gel: Results From a Phase III Controlled Trial

Authors

Abstract

Topics & Keywords

Publication Details